Drug Discovery

Our drug discovery teams, operating across Europe and North America, integrate medicinal chemistry in vitro biology, and ADME studies to generate consistent, decision-ready data. This approach helps you understand compound behaviour earlier, refine design strategy and progress candidates confidently toward IND. 

Our integrated drug discovery CRO services 

With Symeres your small-molecule program stays visible, connected, and adaptable from discovery through IND. With chemistry, biology, and ADME-tox expertise working under one system, you get faster data flow and fewer handoffs. Transparent communication and agile planning mean you always know what’s working, what’s next and how to stay on track 

Projects can run as standalone studies or as coordinated, multi-disciplinary programs. 

hit generation

Hit Generation

Discover novel starting points with our advanced screening technologies and expert medicinal chemistry insight.

Hit-to-Lead

Hit-to-Lead

Transform initial hits into validated leads through iterative chemistry, screening, and early ADME profiling.

lead optimization

Lead Optimization

Refine promising compounds with data-driven chemistry, ADME-Tox profiling, and biology integration to maximize success.

computational chemistry

Computational Chemistry

Accelerate decision-making with predictive modelling, molecular design, and multiparameter optimization.

Rapid Analog Synthesis

Rapid Analog Synthesis

Swiftly design, synthesize, and purify compound arrays to accelerate hit exploration and support lead optimization.

Integrated Drug Discovery

Integrated Drug Discovery

Advance from hit to clinical candidate with a seamless, end-to-end partnership combining chemistry, biology, and ADME-Tox expertise.

Connecting discovery and development 

Integrated discovery and development mean fewer variables and faster scale-up. Shared teams, connected systems and transparent open communication carry your methods forward, so scale-up starts from a solid scientific foundation, not from scratch 

Your discovery and development partner 

Symeres support small-molecule programs from discovery through IND with openness, agility and scientific depth. Our connected teams in Europe and North America provide medicinal chemistry, computational chemistry, synthetic chemistry, and specialty chemistry services integrated with biology, ADME-tox, and CMC development. 

We share data transparently, adapt quickly to new results, and stay accountable from first experiments to IND, to keep your progress clear, connected and continuous. Projects can run as standalone studies or as coordinated, multi-disciplinary programs. 

Feel free to contact us!

Curious to know more about what can we do for you? Get in touch and let’s start a conversation.

Contact us